-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel Cancer Biomarkers & Biospecimens.
Date: December 14, 2017.
Time: 1:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove 9609 Medical Center Drive, Room 7W106 Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Reed A. Graves, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W106 Bethesda, MD 20892-9750, 240-276-6384 gravesr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Start SignatureDated: October 26, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-23814 Filed 10-31-17; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Published:
- 11/01/2017
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2017-23814
- Dates:
- December 14, 2017.
- Pages:
- 50654-50654 (1 pages)
- PDF File:
- 2017-23814.pdf